Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $1.17 million. The enterprise value is -$9.17 million.
Important Dates
The last earnings date was Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 1.50 million shares outstanding. The number of shares has increased by 305.49% in one year.
| Current Share Class | 1.79M |
| Shares Outstanding | 1.50M |
| Shares Change (YoY) | +305.49% |
| Shares Change (QoQ) | +749.61% |
| Owned by Insiders (%) | 9.10% |
| Owned by Institutions (%) | 0.37% |
| Float | 1.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.11 |
| P/TBV Ratio | 0.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.79 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -524.54 |
Financial Efficiency
Return on equity (ROE) is -119.72% and return on invested capital (ROIC) is -87.82%.
| Return on Equity (ROE) | -119.72% |
| Return on Assets (ROA) | -55.21% |
| Return on Invested Capital (ROIC) | -87.82% |
| Return on Capital Employed (ROCE) | -95.05% |
| Weighted Average Cost of Capital (WACC) | -0.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $35,070 in taxes.
| Income Tax | 35,070 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.27% in the last 52 weeks. The beta is -1.05, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.05 |
| 52-Week Price Change | -98.27% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 24.00 |
| Relative Strength Index (RSI) | 22.94 |
| Average Volume (20 Days) | 93,899 |
Short Selling Information
The latest short interest is 103,059, so 6.87% of the outstanding shares have been sold short.
| Short Interest | 103,059 |
| Short Previous Month | 132,651 |
| Short % of Shares Out | 6.87% |
| Short % of Float | 6.95% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.83M |
| Pretax Income | -6.60M |
| Net Income | -6.64M |
| EBITDA | -7.82M |
| EBIT | -7.83M |
| Earnings Per Share (EPS) | -$17.05 |
Full Income StatementBalance Sheet
The company has $10.35 million in cash and $7,977 in debt, with a net cash position of $10.34 million or $6.89 per share.
| Cash & Cash Equivalents | 10.35M |
| Total Debt | 7,977 |
| Net Cash | 10.34M |
| Net Cash Per Share | $6.89 |
| Equity (Book Value) | 8.24M |
| Book Value Per Share | 7.09 |
| Working Capital | 8.12M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.55M |
| FCF Per Share | -$3.70 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
